{"schema_version":"secwatch.filing_event.v1","accession":"0001628171-26-000004","form_type":"8-K","ticker":"RVMD","cik":"0001628171","company_name":"Revolution Medicines, Inc.","filed_at":"2026-10-13T20:32:09+00:00","discovered_at":"2026-10-13T20:33:00.248634+00:00","generated_at":"2026-10-13T20:33:03.221793+00:00","sec_items":["2.03","8.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Revolution Medicines draws $250M Tranche A loan after FDA approves RASONQUE for pancreatic cancer","bullets":["Tranche A Loan of $250.0M funded Oct 8, 2026, triggered by FDA approval of RASONQUE (daraxonrasib) for metastatic pancreatic adenocarcinoma after at least one prior systemic therapy.","Interest at 3-month Term SOFR, floor of 3.50%, plus 5.75%, payable quarterly in arrears; interest-only with principal due Oct 8, 2032.","Company paid Royalty Pharma a $5.0M draw fee; up to $500.0M more available under the $750.0M senior secured facility subject to milestones.","Prepayment terms: make-whole plus 3.0% premium before the 2nd anniversary, 3.0% before the 3rd, and 1.0% thereafter.","Company elected not to deliver a Tranche 3 Notice by the Oct 10, 2026 deadline, forgoing up to $250.0M and selling no incremental revenue participation right."],"urls":{"canonical":"https://secwatch.observer/filing/0001628171-26-000004","json":"https://secwatch.observer/filing/0001628171-26-000004.json","markdown":"https://secwatch.observer/filing/0001628171-26-000004.md","text":"https://secwatch.observer/filing/0001628171-26-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628171/000162817126000004/0001628171-26-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628171/000162817126000004/rvmd-20261008.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-13T20:33:03.221793+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}